HLscience Co. Ltd Cash Flow-to-Debt Ratio
HLscience Co. Ltd cash flow-to-debt ratio. HLscience Co. Ltd (239610) has a Cash Flow-to-Debt Ratio of -0.93x as of September 2025, meaning its operating cash flow of ₩-2.01 Billion could theoretically repay -1% of its total liabilities (₩2.15 Billion) in one year. Check HLscience Co. Ltd (239610) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of HLscience Co. Ltd (2014–2024)
Cash flow-to-debt ratio of HLscience Co. Ltd from 2014 to 2024. Historical debt coverage capacity for HLscience Co. Ltd across 11 annual periods. Check HLscience Co. Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
HLscience Co. Ltd Cash Flow-to-Debt Ratio by Year (2014–2024)
HLscience Co. Ltd cash flow-to-debt ratio by year from 2014 to 2024. Year-by-year debt coverage analysis for HLscience Co. Ltd. For the full cash flow conversion analysis, see HLscience Co. Ltd (239610) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.11x | ₩-3.59 Billion | ₩3.23 Billion | ▼ -91.6% |
| 2023 | -0.58x | ₩-1.96 Billion | ₩3.38 Billion | ▼ -167.4% |
| 2022 | 0.86x | ₩3.95 Billion | ₩4.60 Billion | ▼ -13.7% |
| 2021 | 1.00x | ₩10.56 Billion | ₩10.61 Billion | ▼ -25.4% |
| 2020 | 1.33x | ₩14.97 Billion | ₩11.22 Billion | ▼ -17.6% |
| 2019 | 1.62x | ₩21.38 Billion | ₩13.21 Billion | ▲ +4.7% |
| 2018 | 1.55x | ₩13.02 Billion | ₩8.42 Billion | ▲ +21.9% |
| 2017 | 1.27x | ₩5.83 Billion | ₩4.60 Billion | ▲ +0.8% |
| 2016 | 1.26x | ₩5.53 Billion | ₩4.39 Billion | ▲ +16.0% |
| 2015 | 1.08x | ₩3.10 Billion | ₩2.86 Billion | ▲ +70.2% |
| 2014 | 0.64x | ₩2.31 Billion | ₩3.63 Billion | — |